跳至主要内容
临床试验/PACTR202002892187265
PACTR202002892187265Other未知

The Effect of ß-glucan Prebiotic Fibre (Oats) on the Gut Microbiome of Chronic Kidney Disease Patients (Stage IV and V) and Impact on Kidney Function.

o sponsors0 个研究点目标入组 70 人开始时间: 2020年2月11日最近更新:
适应症

试验速览

阶段
未知
状态
Other
发起方
入组人数
70

研究概览

简要总结

Results will be reported as per outcome statistical summary in the document below

研究设计

研究类型
Interventional

入排标准

年龄范围
45 Year(s) 至 64 Year(s)(—)
性别
All

入选标准

  • Patients with CKD stage 4 (GFR 15-29 ml/min) and 5 (GFR<15 ml/min) pre-dialysis patients attending the Tygerberg Renal Outpatient Clinic.
  • Patients have to be 18 years or older and able to give informed written consent.

排除标准

  • Patients on antibiotics, prebiotics or probiotic supplements currently or in the past 4 weeks.
  • Patients with inflammatory bowel disease, bowel malignancy, previous colorectal surgery (or any other serious bowel disorder)
  • Pregnancy, diabetes mellitus, coeliac disease, human immunodeficiency virus (HIV) disease, malignant hypertension, crescentic glomerular nephritis
  • Patients on immunosuppressant medications.
  • CKD patients who are expected to start dialysis within the next 2 months will be excluded.
  • The conditions mentioned above are excluded due to it influencing either the gut microbiome or renal outcomes.

研究者

发起方
o sponsors

相似试验